Issued Patents All Time
Showing 1–24 of 24 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10456456 | Anti-IL-6 vaccine composition | Lucille DESALLAIS, Matthieu Montes | 2019-10-29 |
| 9669077 | Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6 | Lucille DESALLAIS, Mattieu Montes | 2017-06-06 |
| 9301997 | Method of vaccination for limiting articular inflammation in rheumatoid arthritis and multiple sclerosis by administering IL-23 peptides | Rojo Ratsimandresy | 2016-04-05 |
| 8975399 | Benzenesulfon amide-compound treatment of a pathological condition linked to an excessive effect of TNF | Matthieu Montes, Hadley Mouhsine, Helene Guillemain | 2015-03-10 |
| 8632781 | Immunogenic compounds comprising peptides of IL1β | Marie-Christophe Boissier, Natacha Bessis | 2014-01-21 |
| 8529881 | Peptides for active anti-cytokine immunization | — | 2013-09-10 |
| 8277792 | Peptides for active anti-cytokine immunization | — | 2012-10-02 |
| 8147819 | Peptides for active anti-cytokine immunization | — | 2012-04-03 |
| 8101165 | Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors | Bernard Bizzini, Helene Le Buanec, Daniel Zagury | 2012-01-24 |
| 7892558 | Isolated TNF-alpha peptide and pharmaceutical composition thereof | — | 2011-02-22 |
| 7892529 | Peptides for active anti-cytokine immunization | — | 2011-02-22 |
| 7641895 | Peptides for active anti-cytokine immunization | — | 2010-01-05 |
| 7504479 | Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses | Daniel Zagury | 2009-03-17 |
| 7393523 | Peptides for active anti-cytokine immunization | — | 2008-07-01 |
| 7208148 | Chemically modified cytokines | Daniel Zagury | 2007-04-24 |
| 7067246 | Method for determining prognosis of HIV infected individuals | Daniel Zagury | 2006-06-27 |
| 7022482 | Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses | Daniel Zagury | 2006-04-04 |
| 7022326 | Carboxymethylated retroviral regulatory proteins and interferon-α | Jay Rappaport, Miguel Carcagno | 2006-04-04 |
| 6878370 | Chemically modified TNF-α | Daniel Zagury | 2005-04-12 |
| 6455045 | Immunogenic compounds with in particular an anti-cytokine effect, preparation process, pharmaceutical compositions and kits containing them | Daniel Zagury, Bernard Bizzini | 2002-09-24 |
| 6420141 | Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids | Jay Rappaport, Miguel Carcagno | 2002-07-16 |
| 6200575 | Non-toxic immunogens derived from a retroviral regulatory protein antibodies preparation process and pharmaceutical compositions comprising them | Bernard Bizzini, Daniel Zagury | 2001-03-13 |
| 6132721 | Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same | Bernard Bizzini, Daniel Zagury | 2000-10-17 |
| 6093405 | Inactive but immunogenic cytokines, pharmaceutical compositions containing same, and methods of treating homeostatic disorders associated with an overproduction of cytokines | Daniel Zagury, Bernard Bizzini | 2000-07-25 |